Conversely, PAK2 is also reported to upregulate the expression of MYC in a β-catenin-dependent manner that induces PKM2 expression, leading to cellular proliferation in an HNSCC model [76]. The gene discussed is MYC; the disease is head and neck squamous cell carcinoma.